Viveve Medical, Inc. (VIVE)
USD 0.0
(100.0%)
USD 0.0
(100.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2021 | 6.42 Million USD | 17.28% |
| 2020 | 5.47 Million USD | -16.57% |
| 2019 | 6.56 Million USD | -64.54% |
| 2018 | 18.51 Million USD | 21.12% |
| 2017 | 15.28 Million USD | 114.09% |
| 2016 | 7.14 Million USD | 393.5% |
| 2015 | 1.44 Million USD | 1507.78% |
| 2014 | 90 Thousand USD | -92.94% |
| 2013 | 1.27 Million USD | 17.96% |
| 2012 | 1.08 Million USD | 60.95% |
| 2011 | 671 Thousand USD | -82.84% |
| 2010 | 3.91 Million USD | -17.0% |
| 2009 | 4.71 Million USD | -11.61% |
| 2008 | 5.33 Million USD | -11.23% |
| 2007 | 6 Million USD | -15.98% |
| 2006 | 7.14 Million USD | -6.42% |
| 2005 | 7.63 Million USD | 0.83% |
| 2004 | 7.57 Million USD | -9.13% |
| 2003 | 8.33 Million USD | -5.7% |
| 2002 | 8.83 Million USD | -9.63% |
| 2001 | 9.78 Million USD | -4.49% |
| 2000 | 10.24 Million USD | -12.0% |
| 1999 | 11.63 Million USD | 104.14% |
| 1998 | 5.7 Million USD | -35.96% |
| 1997 | 8.9 Million USD | -25.21% |
| 1996 | 11.9 Million USD | -10.53% |
| 1995 | 13.3 Million USD | 155.77% |
| 1994 | 5.2 Million USD | 57.58% |
| 1993 | 3.3 Million USD | 37.5% |
| 1992 | 2.4 Million USD | 2300.0% |
| 1991 | 100 Thousand USD | 0.0% |
| 1990 | 100 Thousand USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2022 Q3 | 1.68 Million USD | -6.18% |
| 2022 Q2 | 1.79 Million USD | 9.38% |
| 2022 Q1 | 1.64 Million USD | -3.81% |
| 2021 Q2 | 1.65 Million USD | 14.07% |
| 2021 Q3 | 1.61 Million USD | -2.3% |
| 2021 Q4 | 1.7 Million USD | 5.57% |
| 2021 FY | 6.42 Million USD | 17.28% |
| 2021 Q1 | 1.45 Million USD | -25.53% |
| 2020 Q3 | 1.52 Million USD | 116.48% |
| 2020 Q1 | 1.3 Million USD | -10.13% |
| 2020 Q2 | 704 Thousand USD | -46.01% |
| 2020 Q4 | 1.94 Million USD | 27.76% |
| 2020 FY | 5.47 Million USD | -16.57% |
| 2019 Q3 | 1.05 Million USD | 0.0% |
| 2019 Q1 | 3.01 Million USD | -32.65% |
| 2019 Q4 | 1.45 Million USD | 37.93% |
| 2019 Q2 | 1.05 Million USD | -65.07% |
| 2019 FY | 6.56 Million USD | -64.54% |
| 2018 Q3 | 4.82 Million USD | -12.74% |
| 2018 Q1 | 3.69 Million USD | -27.48% |
| 2018 Q2 | 5.52 Million USD | 49.36% |
| 2018 FY | 18.51 Million USD | 21.12% |
| 2018 Q4 | 4.47 Million USD | -7.24% |
| 2017 Q1 | 3.04 Million USD | 24.02% |
| 2017 FY | 15.28 Million USD | 114.09% |
| 2017 Q4 | 5.1 Million USD | 25.33% |
| 2017 Q3 | 4.07 Million USD | 32.31% |
| 2017 Q2 | 3.07 Million USD | 1.15% |
| 2016 Q3 | 1.84 Million USD | 18.83% |
| 2016 Q4 | 2.45 Million USD | 32.61% |
| 2016 Q1 | 1.28 Million USD | 70.74% |
| 2016 Q2 | 1.55 Million USD | 21.18% |
| 2016 FY | 7.14 Million USD | 393.5% |
| 2015 Q2 | 73 Thousand USD | 92.11% |
| 2015 Q3 | 584 Thousand USD | 700.0% |
| 2015 Q1 | 38 Thousand USD | 48.87% |
| 2015 FY | 1.44 Million USD | 1507.78% |
| 2015 Q4 | 752 Thousand USD | 28.77% |
| 2014 Q3 | 17.18 Thousand USD | -76.47% |
| 2014 FY | 90 Thousand USD | -92.94% |
| 2014 Q1 | 54 Thousand USD | -73.66% |
| 2014 Q2 | 73 Thousand USD | 35.19% |
| 2014 Q4 | 25.52 Thousand USD | 48.57% |
| 2013 Q3 | 348 Thousand USD | -6.45% |
| 2013 Q1 | 348 Thousand USD | -28.25% |
| 2013 FY | 1.27 Million USD | 17.96% |
| 2013 Q4 | 205 Thousand USD | -41.09% |
| 2013 Q2 | 372 Thousand USD | 6.9% |
| 2012 Q3 | 212 Thousand USD | -41.6% |
| 2012 Q2 | 363 Thousand USD | 1715.0% |
| 2012 Q1 | 20 Thousand USD | -89.42% |
| 2012 FY | 1.08 Million USD | 60.95% |
| 2012 Q4 | 485 Thousand USD | 128.77% |
| 2011 Q4 | 189 Thousand USD | 600.0% |
| 2011 FY | 671 Thousand USD | -82.84% |
| 2011 Q2 | 398 Thousand USD | 598.25% |
| 2011 Q1 | 57 Thousand USD | -93.92% |
| 2011 Q3 | 27 Thousand USD | -93.22% |
| 2010 FY | 3.91 Million USD | -17.0% |
| 2010 Q3 | 892 Thousand USD | -12.46% |
| 2010 Q1 | 1.06 Million USD | 17.87% |
| 2010 Q2 | 1.01 Million USD | -4.05% |
| 2010 Q4 | 937 Thousand USD | 5.04% |
| 2009 Q3 | 1.02 Million USD | -16.15% |
| 2009 Q1 | 1.56 Million USD | 24.96% |
| 2009 Q4 | 901 Thousand USD | -11.93% |
| 2009 FY | 4.71 Million USD | -11.61% |
| 2009 Q2 | 1.22 Million USD | -22.14% |
| 2008 Q1 | 1.16 Million USD | -6.41% |
| 2008 FY | 5.33 Million USD | -11.23% |
| 2008 Q4 | 1.25 Million USD | -21.53% |
| 2008 Q3 | 1.59 Million USD | 21.98% |
| 2008 Q2 | 1.31 Million USD | 12.16% |
| 2007 FY | 6 Million USD | -15.98% |
| 2007 Q4 | 1.24 Million USD | -6.24% |
| 2007 Q2 | 1.93 Million USD | 29.4% |
| 2007 Q1 | 1.49 Million USD | -14.54% |
| 2007 Q3 | 1.33 Million USD | -31.11% |
| 2006 Q2 | 1.94 Million USD | 2.86% |
| 2006 FY | 7.14 Million USD | -6.42% |
| 2006 Q1 | 1.88 Million USD | 4.31% |
| 2006 Q4 | 1.74 Million USD | 11.49% |
| 2006 Q3 | 1.56 Million USD | -19.35% |
| 2005 FY | 7.63 Million USD | 0.83% |
| 2005 Q4 | 1.81 Million USD | -4.68% |
| 2005 Q3 | 1.9 Million USD | -4.14% |
| 2005 Q1 | 1.94 Million USD | -14.1% |
| 2005 Q2 | 1.98 Million USD | 2.01% |
| 2004 Q3 | 1.6 Million USD | -10.58% |
| 2004 Q2 | 1.79 Million USD | -5.92% |
| 2004 Q1 | 1.9 Million USD | -18.24% |
| 2004 FY | 7.57 Million USD | -9.13% |
| 2004 Q4 | 2.26 Million USD | 40.85% |
| 2003 Q2 | 2.01 Million USD | 15.97% |
| 2003 FY | 8.33 Million USD | -5.7% |
| 2003 Q3 | 2.25 Million USD | 12.08% |
| 2003 Q4 | 2.33 Million USD | 3.59% |
| 2003 Q1 | 1.73 Million USD | -22.73% |
| 2002 Q4 | 2.24 Million USD | 12.48% |
| 2002 FY | 8.83 Million USD | -9.63% |
| 2002 Q3 | 1.99 Million USD | -8.44% |
| 2002 Q2 | 2.17 Million USD | -9.96% |
| 2002 Q1 | 2.42 Million USD | -3.24% |
| 2001 Q4 | 2.5 Million USD | 6.11% |
| 2001 Q3 | 2.35 Million USD | -8.68% |
| 2001 Q2 | 2.58 Million USD | 10.25% |
| 2001 Q1 | 2.34 Million USD | -1.18% |
| 2001 FY | 9.78 Million USD | -4.49% |
| 2000 Q1 | 1.74 Million USD | -36.33% |
| 2000 Q2 | 3.58 Million USD | 105.51% |
| 2000 Q3 | 2.54 Million USD | -28.8% |
| 2000 Q4 | 2.36 Million USD | -7.06% |
| 2000 FY | 10.24 Million USD | -12.0% |
| 1999 Q4 | 2.73 Million USD | 9.44% |
| 1999 Q3 | 2.5 Million USD | -28.57% |
| 1999 Q2 | 3.5 Million USD | 25.0% |
| 1999 Q1 | 2.8 Million USD | 12.0% |
| 1999 FY | 11.63 Million USD | 104.14% |
| 1998 Q1 | 900 Thousand USD | -55.0% |
| 1998 Q3 | 1.6 Million USD | 128.57% |
| 1998 Q4 | 2.5 Million USD | 56.25% |
| 1998 FY | 5.7 Million USD | -35.96% |
| 1998 Q2 | 700 Thousand USD | -22.22% |
| 1997 Q2 | 3.4 Million USD | 112.5% |
| 1997 Q3 | 1.9 Million USD | -44.12% |
| 1997 FY | 8.9 Million USD | -25.21% |
| 1997 Q1 | 1.6 Million USD | -48.39% |
| 1997 Q4 | 2 Million USD | 5.26% |
| 1996 Q1 | 4.8 Million USD | -35.14% |
| 1996 Q4 | 3.1 Million USD | 24.0% |
| 1996 Q3 | 2.5 Million USD | 78.57% |
| 1996 Q2 | 1.4 Million USD | -70.83% |
| 1996 FY | 11.9 Million USD | -10.53% |
| 1995 Q2 | 1.5 Million USD | -48.28% |
| 1995 Q3 | 1.6 Million USD | 6.67% |
| 1995 Q4 | 7.4 Million USD | 362.5% |
| 1995 Q1 | 2.9 Million USD | 61.11% |
| 1995 FY | 13.3 Million USD | 155.77% |
| 1994 Q1 | 1.4 Million USD | 16.67% |
| 1994 FY | 5.2 Million USD | 57.58% |
| 1994 Q3 | 1 Million USD | 0.0% |
| 1994 Q4 | 1.8 Million USD | 80.0% |
| 1994 Q2 | 1 Million USD | -28.57% |
| 1993 Q4 | 1.2 Million USD | 71.43% |
| 1993 FY | 3.3 Million USD | 37.5% |
| 1993 Q1 | 800 Thousand USD | -11.11% |
| 1993 Q2 | 600 Thousand USD | -25.0% |
| 1993 Q3 | 700 Thousand USD | 16.67% |
| 1992 Q4 | 900 Thousand USD | 28.57% |
| 1992 Q1 | 200 Thousand USD | 0.0% |
| 1992 Q3 | 700 Thousand USD | 16.67% |
| 1992 Q2 | 600 Thousand USD | 200.0% |
| 1992 FY | 2.4 Million USD | 2300.0% |
| 1991 Q4 | - USD | -100.0% |
| 1991 Q2 | 100 Thousand USD | 0.0% |
| 1991 Q3 | 100 Thousand USD | 0.0% |
| 1991 Q1 | 100 Thousand USD | 0.0% |
| 1991 FY | 100 Thousand USD | 0.0% |
| 1990 FY | 100 Thousand USD | 0.0% |
| 1990 Q3 | 100 Thousand USD | 0.0% |
| 1990 Q2 | 100 Thousand USD | 0.0% |
| 1990 Q1 | 100 Thousand USD | 0.0% |
| 1990 Q4 | - USD | -100.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acutus Medical, Inc. | 7.16 Million USD | 10.302% |
| Cerus Corporation | 156.36 Million USD | 95.89% |
| OrthoPediatrics Corp. | 148.73 Million USD | 95.679% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -563.359% |
| Talis Biomedical Corporation | 412 Thousand USD | -1459.709% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | 53.438% |
| Inogen, Inc. | 315.66 Million USD | 97.964% |
| Spectral AI, Inc. | 18.05 Million USD | 64.411% |
| Nano-X Imaging Ltd. | 9.9 Million USD | 35.124% |
| CVRx, Inc. | 39.29 Million USD | 83.647% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -897.826% |
| Orthofix Medical Inc. | 746.64 Million USD | 99.139% |
| Venus Concept Inc. | 76.35 Million USD | 91.584% |
| Accelerate Diagnostics, Inc. | 12.05 Million USD | 46.712% |
| Bioventus Inc. | 512.34 Million USD | 98.746% |
| BrainsWay Ltd. | 31.78 Million USD | 79.783% |
| Envoy Medical, Inc. | 316 Thousand USD | -1933.544% |
| electroCore, Inc. | 16.03 Million USD | 59.913% |
| IceCure Medical Ltd | 3.22 Million USD | -99.009% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -164.662% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -1660.553% |
| MaxCyte, Inc. | 41.28 Million USD | 84.436% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -229.126% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -5702.362% |
| PAVmed Inc | 2.45 Million USD | -162.072% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | 71.464% |
| RxSight, Inc. | 89.07 Million USD | 92.786% |
| Sight Sciences, Inc. | 81.05 Million USD | 92.072% |
| SI-BONE, Inc. | 138.88 Million USD | 95.373% |
| TELA Bio, Inc. | 58.45 Million USD | 89.007% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | 65.286% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | 96.566% |
| LivaNova PLC | 1.15 Billion USD | 99.443% |
| 908 Devices Inc. | 50.22 Million USD | 87.207% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 98.668% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -8240.688% |
| NeuroPace, Inc. | 65.42 Million USD | 90.177% |
| LENSAR, Inc. | 42.16 Million USD | 84.76% |
| Apyx Medical Corporation | 52.34 Million USD | 87.725% |
| Cutera, Inc. | 212.36 Million USD | 96.974% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | 80.736% |
| BioSig Technologies, Inc. | 18 Thousand USD | -35600.0% |
| Anika Therapeutics, Inc. | 166.66 Million USD | 96.144% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | 73.175% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 99.583% |
| Axonics, Inc. | 366.37 Million USD | 98.246% |
| Outset Medical, Inc. | 130.37 Million USD | 95.071% |
| IRIDEX Corporation | 51.86 Million USD | 87.611% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | 95.282% |
| IRadimed Corporation | 65.56 Million USD | 90.199% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -446.429% |
| INVO Bioscience, Inc. | 3.02 Million USD | -112.741% |
| Telesis Bio, Inc. | 27.5 Million USD | 76.64% |
| Viemed Healthcare, Inc. | 183 Million USD | 96.489% |
| Varex Imaging Corporation | 811 Million USD | 99.208% |
| Quipt Home Medical Corp. | 221.74 Million USD | 97.102% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | 90.643% |
| Dynatronics Corporation | 32.53 Million USD | 80.248% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | 25.951% |
| Semler Scientific, Inc. | 68.18 Million USD | 90.576% |
| InMode Ltd. | 492.04 Million USD | 98.694% |
| Bruker Corporation | 2.96 Billion USD | 99.783% |
| Cytosorbents Corporation | 36.34 Million USD | 82.322% |
| DexCom, Inc. | 3.62 Billion USD | 99.823% |
| Align Technology, Inc. | 3.86 Billion USD | 99.834% |
| ZimVie Inc. | 457.43 Million USD | 98.595% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | 96.671% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -5702.362% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 99.141% |
| Profound Medical Corp. | 7.33 Million USD | 12.345% |
| Insulet Corporation | 1.69 Billion USD | 99.621% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | 94.903% |
| iCAD, Inc. | 17.31 Million USD | 62.894% |
| Nuwellis, Inc. | 8.86 Million USD | 27.505% |
| Biotricity, Inc. | 12.06 Million USD | 46.731% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 98.696% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | -3.562% |
| PAVmed Inc. | 2.45 Million USD | -162.072% |
| BIOLASE, Inc. | 49.16 Million USD | 86.929% |
| Beyond Air, Inc. | 1.15 Million USD | -454.443% |
| FONAR Corporation | 102.88 Million USD | 93.754% |
| AxoGen, Inc. | 159.01 Million USD | 95.959% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 97.658% |
| Inari Medical, Inc. | 493.63 Million USD | 98.698% |
| UFP Technologies, Inc. | 400.07 Million USD | 98.394% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -34448.387% |
| Tenon Medical, Inc. | 2.92 Million USD | -119.467% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | 5.667% |
| AdaptHealth Corp. | 3.2 Billion USD | 99.799% |
| Sintx Technologies, Inc. | 2.62 Million USD | -144.614% |
| NanoVibronix, Inc. | 2.28 Million USD | -181.472% |
| Quanterix Corporation | 122.36 Million USD | 94.749% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | 73.669% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | 96.795% |
| TransMedics Group, Inc. | 241.62 Million USD | 97.34% |
| ReWalk Robotics Ltd. | 13.85 Million USD | 53.616% |
| NeuroMetrix, Inc. | 5.9 Million USD | -8.889% |
| Hyperfine, Inc. | 11.03 Million USD | 41.751% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | 96.109% |
| Biomerica, Inc. | 5.41 Million USD | -18.67% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | 87.291% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | 96.372% |